DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr | ₹25,548 Cr | ₹22,005 Cr |
What is the latest Total Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹37,806 Cr |
Mar2023 | ₹31,580 Cr |
Mar2022 | ₹28,470 Cr |
Mar2021 | ₹25,548 Cr |
Mar2020 | ₹22,005 Cr |
How is Total Liabilities of DR REDDYS LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹37,806 Cr | 19.72 | |
Mar2023 | ₹31,580 Cr | 10.92 | |
Mar2022 | ₹28,470 Cr | 11.44 | |
Mar2021 | ₹25,548 Cr | 16.10 | |
Mar2020 | ₹22,005 Cr | - |
Compare Total Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹93,436.1 Cr | -3.9% | -8% | -13.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,331.0 Cr | -3.3% | -9.1% | 1.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,046.0 Cr | -2.9% | -0.7% | 56% | Stock Analytics | |
CIPLA | ₹113,668.0 Cr | -4.7% | -4.9% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹100,166.0 Cr | -1.7% | -9.2% | 12.9% | Stock Analytics | |
MANKIND PHARMA | ₹95,862.6 Cr | 1% | -4.7% | 11.6% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -3.9% |
-8% |
-13.1% |
SENSEX | -3% |
-4.8% |
-0% |
You may also like the below Video Courses